Daniel Areson, DO
Physical Medicine & Rehabilitation · Paramus, NJNPI 1770902959
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,763 of the $3,719 with a category attached, or 74.3%. 9 manufacturers reported payments, led by Relievant Medsystems, Inc. at 48.8% of the total. Among physical medicine & rehabilitation clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 33 payments — averaging $112.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Relievant Medsystems, Inc.$2K
- Medtronic$1K
- Pacira Pharmaceuticals Incorporated$608
- Axogen$98
- Smith+Nephew$49
- Bioventus LLC$39
- plus $51 from 3 others
What the payments were for
- Travel & lodging$2,76374%
- Food & beverage$95626%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Relievant Medsystems, Inc. | 11 | $1,815 |
| Medtronic | 8 | $1,059 |
| Pacira Pharmaceuticals Incorporated | 6 | $608 |
| Axogen | 2 | $98 |
| Smith+Nephew | 1 | $49 |
| Bioventus LLC | 2 | $39 |
| AbbVie | 1 | $20 |
| Forte Bio-pharma LLC | 1 | $15 |
| Zimvie Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,719 in reported general payments places this provider in the 90th percentile of 434 physical medicine & rehabilitation providers in New Jersey.
See all physical medicine & rehabilitation providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 126 | $746 |
| Diclofenac Sodium | 120 | $608 |
| Tramadol Hcl | 104 | $604 |
| Tizanidine Hcl | 100 | $585 |
| Meloxicam | 129 | $473 |
| Methylprednisolone | 70 | $347 |
| Methocarbamol | 19 | $245 |
| Cyclobenzaprine Hcl | 23 | $175 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 17 | $117 |
| Diazepam | 12 | $17 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Paramus
- Steven EscaldiEdison$70K
- Yekyung KongWest Orange$61K
- Joseph IbrahimBayonne$50K
- Steven KirshblumWest Orange$47K
- Joseph ValenzaChester$29K
- Christine GreissEdison$28K
- Bianca MartinezManasquan$25K
- Jason SmithCedar Knolls$19K
- Sandeep RathiLakewood$14K
- Anand PooleriCamden$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.